{"result": {"id": "d8133a46-4801-478f-b683-b23550291ce5", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>BEANEYT<|>PERSON<|>Researcher involved in the May Measurement Month 2021 blood pressure screening campaign\")  \n##  \n(\"entity\"<|>WANGW<|>PERSON<|>Researcher involved in the May Measurement Month 2021 blood pressure screening campaign\")  \n##  \n(\"entity\"<|>SCHLAICH MP<|>PERSON<|>Researcher involved in the May Measurement Month 2021 blood pressure screening campaign\")  \n##  \n(\"entity\"<|>MANCIAG<|>PERSON<|>Researcher involved in the 2023 ESH hypertension guidelines\")  \n##  \n(\"entity\"<|>KREUTZR<|>PERSON<|>Researcher involved in the 2023 ESH hypertension guidelines\")  \n##  \n(\"entity\"<|>BRUNSTRÖM M<|>PERSON<|>Researcher involved in the 2023 ESH hypertension guidelines\")  \n##  \n(\"entity\"<|>LÖNNEBAKKEN MT<|>PERSON<|>Researcher studying left ventricular hypertrophy regression in hypertension\")  \n##  \n(\"entity\"<|>IZZO R<|>PERSON<|>Researcher studying left ventricular hypertrophy regression in hypertension\")  \n##  \n(\"entity\"<|>MANCUSIC<|>PERSON<|>Researcher studying left ventricular hypertrophy regression in hypertension\")  \n##  \n(\"entity\"<|>MATSUSHITAK<|>PERSON<|>Researcher comparing CKD-EPI and MDRD equations for glomerular filtration rate estimation\")  \n##  \n(\"entity\"<|>MAHMOODIBK<|>PERSON<|>Researcher comparing CKD-EPI and MDRD equations for glomerular filtration rate estimation\")  \n##  \n(\"entity\"<|>WOODWARDM<|>PERSON<|>Researcher comparing CKD-EPI and MDRD equations for glomerular filtration rate estimation\")  \n##  \n(\"entity\"<|>GERSTEIN HC<|>PERSON<|>Researcher studying albuminuria and cardiovascular risk in diabetic/nondiabetic individuals\")  \n##  \n(\"entity\"<|>MANN JF<|>PERSON<|>Researcher studying albuminuria and cardiovascular risk in diabetic/nondiabetic individuals\")  \n##  \n(\"entity\"<|>YIQ<|>PERSON<|>Researcher studying albuminuria and cardiovascular risk in diabetic/nondiabetic individuals\")  \n##  \n(\"entity\"<|>KIM YJ<|>PERSON<|>Researcher studying urinary albumin-creatinine ratio and cardiovascular disease\")  \n##  \n(\"entity\"<|>HWANGSW<|>PERSON<|>Researcher studying urinary albumin-creatinine ratio and cardiovascular disease\")  \n##  \n(\"entity\"<|>LEET<|>PERSON<|>Researcher studying urinary albumin-creatinine ratio and cardiovascular disease\")  \n##  \n(\"entity\"<|>MAYC<|>PERSON<|>Researcher developing modified GFR estimating equations for Chinese CKD patients\")  \n##  \n(\"entity\"<|>ZUOL<|>PERSON<|>Researcher developing modified GFR estimating equations for Chinese CKD patients\")  \n##  \n(\"entity\"<|>CHEN JH<|>PERSON<|>Researcher developing modified GFR estimating equations for Chinese CKD patients\")  \n##  \n(\"entity\"<|>BORGHIC<|>PERSON<|>Researcher studying uric acid and hypertension for cardiovascular risk management\")  \n##  \n(\"entity\"<|>AGNOLETTID<|>PERSON<|>Researcher studying uric acid and hypertension for cardiovascular risk management\")  \n##  \n(\"entity\"<|>CICEROA<|>PERSON<|>Researcher studying uric acid and hypertension for cardiovascular risk management\")  \n##  \n(\"entity\"<|>SCUTERIA<|>PERSON<|>Researcher advocating cognitive function assessment in older hypertensive patients\")  \n##  \n(\"entity\"<|>BENETOSA<|>PERSON<|>Researcher advocating cognitive function assessment in older hypertensive patients\")  \n##  \n(\"entity\"<|>SIERRA C<|>PERSON<|>Researcher advocating cognitive function assessment in older hypertensive patients\")  \n##  \n(\"entity\"<|>MUIESAN ML<|>PERSON<|>Researcher studying smartphone-based ocular fundus photography in acute hypertension\")  \n##  \n(\"entity\"<|>SALVETTIM<|>PERSON<|>Researcher studying smartphone-based ocular fundus photography in acute hypertension\")  \n##  \n(\"entity\"<|>PAINIA<|>PERSON<|>Researcher studying smartphone-based ocular fundus photography in acute hypertension\")  \n##  \n(\"entity\"<|>POLAKJF<|>PERSON<|>Researcher studying carotid-wall intima-media thickness and cardiovascular events\")  \n##  \n(\"entity\"<|>PENCINAMJ<|>PERSON<|>Researcher studying carotid-wall intima-media thickness and cardiovascular events\")  \n##  \n(\"entity\"<|>PENCINAKM<|>PERSON<|>Researcher studying carotid-wall intima-media thickness and cardiovascular events\")  \n##  \n(\"entity\"<|>LAURENTS<|>PERSON<|>Researcher contributing to expert consensus on arterial stiffness\")  \n##  \n(\"entity\"<|>COCKCROFTJ<|>PERSON<|>Researcher contributing to expert consensus on arterial stiffness\")  \n##  \n(\"entity\"<|>VAN BORTELL<|>PERSON<|>Researcher contributing to expert consensus on arterial stiffness\")  \n##  \n(\"entity\"<|>SHENGCS<|>PERSON<|>Researcher studying brachial-ankle pulse wave velocity as a mortality predictor\")  \n##  \n(\"entity\"<|>LIY<|>PERSON<|>Researcher studying brachial-ankle pulse wave velocity as a mortality predictor\")  \n##  \n(\"entity\"<|>LILH<|>PERSON<|>Researcher studying brachial-ankle pulse wave velocity as a mortality predictor\")  \n##  \n(\"entity\"<|>TOMIYAMAH<|>PERSON<|>Researcher reviewing brachial-ankle PWV techniques\")  \n##  \n(\"entity\"<|>SHIINAK<|>PERSON<|>Researcher reviewing brachial-ankle PWV techniques\")  \n##  \n(\"entity\"<|>MURABITOJM<|>PERSON<|>Researcher investigating ankle-brachial index in the elderly using Framingham study data\")  \n##  \n(\"entity\"<|>EVANSJC<|>PERSON<|>Researcher investigating ankle-brachial index in the elderly using Framingham study data\")  \n##  \n(\"entity\"<|>LARSON MG<|>PERSON<|>Researcher investigating ankle-brachial index in the elderly using Framingham study data\")  \n##  \n(\"relationship\"<|>BEANEYT<|>MAY MEASUREMENT MONTH 2021<|>BeaneyT was a researcher in the May Measurement Month 2021 campaign<|>7\")  \n##  \n(\"relationship\"<|>WANGW<|>MAY MEASUREMENT MONTH 2021<|>WangW was a researcher in the May Measurement Month 2021 campaign<|>7\")  \n##  \n(\"relationship\"<|>SCHLAICH MP<|>MAY MEASUREMENT MONTH 2021<|>Schlaich MP was a researcher in the May Measurement Month 2021 campaign<|>7\")  \n##  \n(\"relationship\"<|>MANCIAG<|>EUROPEAN SOCIETY OF HYPERTENSION<|>ManciaG contributed to the 2023 ESH hypertension guidelines<|>8\")  \n##  \n(\"relationship\"<|>KREUTZR<|>EUROPEAN SOCIETY OF HYPERTENSION<|>KreutzR contributed to the 2023 ESH hypertension guidelines<|>8\")  \n##  \n(\"relationship\"<|>BRUNSTRÖM M<|>EUROPEAN SOCIETY OF HYPERTENSION<|>Brunström M contributed to the 2023 ESH hypertension guidelines<|>8\")  \n##  \n(\"relationship\"<|>LÖNNEBAKKEN MT<|>CAMPANIA SALUTE NETWORK<|>Lønnebakken MT conducted research through the Campania Salute Network<|>7\")  \n##  \n(\"relationship\"<|>IZZO R<|>CAMPANIA SALUTE NETWORK<|>Izzo R conducted research through the Campania Salute Network<|>7\")  \n##  \n(\"relationship\"<|>MANCUSIC<|>CAMPANIA SALUTE NETWORK<|>MancusiC conducted research through the Campania Salute Network<|>7\")  \n##  \n(\"relationship\"<|>MURABITOJM<|>FRAMINGHAM STUDY<|>MurabitoJM used data from the Framingham Study<|>8\")  \n##  \n(\"relationship\"<|>EVANSJC<|>FRAMINGHAM STUDY<|>EvansJC used data from the Framingham Study<|>8\")  \n##  \n(\"relationship\"<|>LARSON MG<|>FRAMINGHAM STUDY<|>Larson MG used data from the Framingham Study<|>8\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558893, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 2089, "prompt_tokens": 3594, "total_tokens": 5683, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3520}, "prompt_cache_hit_tokens": 3520, "prompt_cache_miss_tokens": 74}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Higherarm versuslow- erarm systolic blood pressure and cardiovascular outcomes: a meta-analysis   of   individual   participant   data    from    the INTERPRESS-IPD collaboration[J].  Hypertension, 2022, 79\n(10) :2328-2335.\n[107]  BeaneyT, WangW , Schlaich MP, etal.  Globalblood pressure screeningduring theCOVID-19pandemic: resultsfrom theMay MeasurementMonth2021 campaign[J]. J Hypertens, 2023, 41\n(9) :1446-1455.\n[108]  ManciaG, KreutzR, Brunstr?m M, etal. 2023ESH guidelines forthe management of arterialhypertension the taskforce for the managementofarterialhypertensionoftheEuropeanSociety of Hypertension: endorsed by the InternationalSociety of Hy- pertension(ISH) and the European Renal Association (ERA)  [J]. J Hypertens,2023,41(12) :1874-2071.\n[109]  L?nnebakken MT, Izzo R, MancusiC, et al.  Left ventricular hypertrophy regression during antihypertensive treatmentin an outpatientclinic(thecampaniasalutenetwork)[J]. JAm Heart Assoc,2017,6(3) :e004152.\n[110]  MatsushitaK, MahmoodiBK, WoodwardM, etal. Comparison ofrisk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate[J].   JAMA,2012,307(18) :1941-1951.\n[111]  Gerstein HC, Mann JF, YiQ, et al.  Albuminuria and risk of cardiovascularevents, death, and heart failure in diabetic and nondiabeticindividuals[J]. JAMA,2001,286(4) :421-426.\n\n\n[112]  Kim YJ, HwangSW , LeeT, etal. Associationbetweenurinary albumin creatinine ratio and cardiovascular disease[J].  PLoS One,2023,18(3) :e0283083.\n[113]  MaYC, ZuoL, Chen JH, etal. Modified glomerularfiltration rateestimating equationforChinesepatientswithchronickidney disease[J]. JAm SocNephrol,2006,17(10) :2937-2944.\n[114]  BorghiC, AgnolettiD, CiceroA, etal. Uricacidandhyperten- sion: a review of evidence and future perspectives for the man- agementofcardiovascular risk[J]. Hypertension, 2022, 79(9) :  1927-1936.\n[115]  ScuteriA, BenetosA, Sierra C, et al.  Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how-a decision-making sup- portfrom theworking group on‘hypertension and the brain'of the European Society of Hypertension and from the European GeriatricMedicineSociety[J]. J Hypertens,2021,39(1) :90-100.\n[116]  Muiesan ML, SalvettiM, PainiA, etal.  Ocularfundusphotog- raphywith a smartphonedevicein acutehypertension[J]. J Hy- pertens,2017,35(8) :1660-1665.\n[117]  中华预防医学会健康风险评估与控制专业委员会 , 中华医学会 心血管病学分会 , 中国健康管理协会健康体检分会.  基于眼底图 像应用人工智能技术评估心血管病发病风险的专家共识[J]. 中 华内科杂志 ,2024,63(1) :28-34.\n[118]  PolakJF, PencinaMJ, PencinaKM, etal. Carotid-wallintima- media thickness and cardiovascular events[J]. N EnglJ Med,  2011,365(3) :213-221.\n[119]  LaurentS, CockcroftJ, Van BortelL, etal. Expertconsensus documenton arterialstiffness: methodologicalissuesandclinical applications[J]. EurHeartJ,2006,27(21) :2588-2605.\n[120]  ShengCS, LiY, LiLH, etal. Brachial-anklepulsewaveveloci- ty asa predictor of mortality in elderly Chinese[J]. Hyperten- sion,2014,64(5) :1124-1130.\n[121]  Tomiyama H, ShiinaK.  Stateofthe artreview: brachial-ankle PWV[J]. JAtherosclerThromb,2020,27(7) :621-636.\n[122]  MurabitoJM, EvansJC, Larson MG, etal. Theankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham study[J]. Arch Intern Med, 2003, 163\n(16) :1939-1942\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>INTERPRESS-IPD COLLABORATION<|>ORGANIZATION<|>A research collaboration focused on individual participant data meta-analysis of blood pressure and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>EUROPEAN SOCIETY OF HYPERTENSION<|>ORGANIZATION<|>A professional organization that develops guidelines for the management of arterial hypertension\")  \n##  \n(\"entity\"<|>INTERNATIONAL SOCIETY OF HYPERTENSION<|>ORGANIZATION<|>An organization endorsing hypertension management guidelines alongside the European Society of Hypertension\")  \n##  \n(\"entity\"<|>EUROPEAN RENAL ASSOCIATION<|>ORGANIZATION<|>An organization endorsing hypertension management guidelines\")  \n##  \n(\"entity\"<|>CAMPANIA SALUTE NETWORK<|>ORGANIZATION<|>A network involved in outpatient clinic studies on left ventricular hypertrophy regression during antihypertensive treatment\")  \n##  \n(\"entity\"<|>CHINESE PREVENTIVE MEDICINE ASSOCIATION<|>ORGANIZATION<|>An organization contributing to expert consensus on cardiovascular risk assessment using AI and fundus images\")  \n##  \n(\"entity\"<|>CHINESE MEDICAL ASSOCIATION<|>ORGANIZATION<|>A professional body involved in cardiovascular disease research and guidelines\")  \n##  \n(\"entity\"<|>CHINA HEALTH MANAGEMENT ASSOCIATION<|>ORGANIZATION<|>An association involved in health risk assessment and management\")  \n##  \n(\"entity\"<|>FRAMINGHAM STUDY<|>EVENT<|>A long-term epidemiological study investigating risk factors for stroke, coronary disease, and death\")  \n##  \n(\"entity\"<|>MAY MEASUREMENT MONTH 2021<|>EVENT<|>A global blood pressure screening campaign during the COVID-19 pandemic\")  \n##  \n(\"relationship\"<|>EUROPEAN SOCIETY OF HYPERTENSION<|>INTERNATIONAL SOCIETY OF HYPERTENSION<|>Both organizations endorsed the 2023 ESH guidelines for hypertension management<|>8\")  \n##  \n(\"relationship\"<|>EUROPEAN SOCIETY OF HYPERTENSION<|>EUROPEAN RENAL ASSOCIATION<|>Both organizations endorsed the 2023 ESH guidelines for hypertension management<|>8\")  \n##  \n(\"relationship\"<|>CHINESE PREVENTIVE MEDICINE ASSOCIATION<|>CHINESE MEDICAL ASSOCIATION<|>Both organizations contributed to the expert consensus on cardiovascular risk assessment<|>7\")  \n##  \n(\"relationship\"<|>CHINESE PREVENTIVE MEDICINE ASSOCIATION<|>CHINA HEALTH MANAGEMENT ASSOCIATION<|>Both organizations contributed to the expert consensus on cardiovascular risk assessment<|>7\")  \n##  \n(\"relationship\"<|>MAY MEASUREMENT MONTH 2021<|>COVID-19 PANDEMIC<|>The blood pressure screening campaign was conducted during the COVID-19 pandemic<|>6\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_682f0c9b9e11e33e0b54d66e9e7cf9fcdfa2e1edba852c8a8d9d2a259c5206cb_v2"}